Cyrus Dugger

FDA Should Not Approve Painkiller Dubbed “Offspring of Vioxx”

From Public Citizen:

FDA Should Not Approve Painkiller Dubbed “Offspring of Vioxx”

It’s Time to Shut the Door on COX-2 Inhibitors, Dr. Sidney Wolfe of Public Citizen Tells FDA Advisory Committee

WASHINGTON, D.C. – Public Citizen today urged the government to reject an application for a new painkiller – Arcoxia – that is in the same class of drugs as Vioxx and, like that drug, is associated with an increased risk of cardiovascular problems.

In testimony to the Food and Drug Administration’s (FDA) Arthritis Advisory Committee, Dr. Sidney Wolfe, director of the Health Research Group at Public Citizen, said the drug should not be approved for sale in the United States, and, in fact, should be pulled from the market in the more than 60 countries where it is sold. (keep reading)

Cyrus Dugger: Author Bio | Other Posts
Posted at 5:52 PM, Apr 12, 2007 in Civil Justice | FDA | Increasing Safety | Under Regulation
Permalink | Email to Friend


Well, the good news is the FDA advisory panel recommended by 20-1 that the drug not be approved.

The bad news is the FDA can approve it anyway. We'll see what happens.

Posted by: Justinian Lane | April 12, 2007 7:38 PM